Clinical and Patient-Reported Outcomes in People Living With HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting
Go back to Clinical and Patient-Reported Outcomes in People Living With HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.80 +0.93 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.87 | 52 Week High | $108.63 | |||
| Open | $126.63 | 52 Week Low | $71.39 | |||
| Day High | $126.63 | P/E | 69.50 | |||
| Day Low | $124.44 | EPS | $1.81 | |||
| Volume | 2,151,348 | |||||
